首页 › 前列腺癌 › 俄亥俄州 › Cincinnati
Cincinnati OH 前列腺癌临床试验
19项针对 前列腺癌的研究正在 Cincinnati及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- Oncology Hematology Care Incorporated, Cincinnati
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- 以及另外 3 项
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- Saint Elizabeth Healthcare Edgewood, Edgewood · 距离 8 英里
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- University of Cincinnati Medical Center, Cincinnati
Real World Prostate Cancer Registry
招募中观察性研究
- Cincinnati Cancer Advisors, Cincinnati
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 113, Cincinnati
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
招募中3 期
- Oncology Hematology Care Incorporated, Cincinnati
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
招募中3 期
- Research Site, Cincinnati
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
招募中3 期
- Urology Group - Solaris Network, Cincinnati
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- TriState Urologic Services PSC Inc. dba The Urology Group, Cincinnati
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 距离 15 英里
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
招募中1 期
- Oncology Hematology Care Incorporated, Cincinnati
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
招募中2 期
- Solaris Health - The Urology Group, Cincinnati
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 以及另外 1 项
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
招募中观察性研究
- The University of Cinncinatti, Cincinnati
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
招募中2 期
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 以及另外 1 项
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
招募中3 期
- Oncology Hematology Care Inc-Kenwood, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Cincinnati
其他城市的 前列腺癌试验
- New York City, NY101 项研究
- Houston, TX73 项研究
- Los Angeles, CA64 项研究
- Boston, MA56 项研究
- Seattle, WA45 项研究
- St. Louis, MO45 项研究
- Chicago, IL45 项研究
- Baltimore, MD45 项研究
- San Francisco, CA44 项研究
- Philadelphia, PA41 项研究
- Nashville, TN40 项研究
- Washington, DC39 项研究
Cincinnati的其他研究
- 非小细胞肺癌31 项研究
- 癌症（所有类型）26 项研究
- 乳腺癌24 项研究
- 心力衰竭22 项研究
- 转移性癌症21 项研究
- 结直肠癌20 项研究
- 肥胖症20 项研究
- 急性髓系白血病20 项研究
- 卵巢癌18 项研究
- 肺癌18 项研究
- 多发性骨髓瘤17 项研究
- 心血管疾病16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。